June 6, 2025 · Form 4 insider transaction
Nemec Sarah bought 125 shares of Bolt Biotherapeutics, Inc. at $5.49 per share, a transaction worth $686.50. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 140 days after the transaction.
Shares acquired under the issuer's Employee Stock Purchase Plan and therefore exempt under Rule 16b-3(c)